SP

Suriya Prakash

Active Director Managing Director DIN 09599316
DIN 09599316 First appointment May 2022 Primary industry Home Appliances
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Suriya Prakash

Data last updated:

Suriya Prakash is a Managing Director at Immuno Cure Rite Medical Equipments Private Limited (since 2022). The company operates in Home Appliances.

DIN 09599316
Primary Designation Managing Director
Industry Home Appliances
First Appointment 09 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director09 May 20222022Active

Board colleagues of Suriya Prakash

NameDINCompanyDesignation
Kaviya09599317Immuno Cure Rite Medical Equipments Private LimitedDirector

Directorship timeline

Open interactive timeline →
Immuno Cure Rite Medical Equipments Private Limited
Premium access

Shareholding and investment profile for Suriya Prakash

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suriya Prakash

Suriya Prakash currently holds 1 directorship: Immuno Cure Rite Medical Equipments Private Limited (Managing Director, since 09 May 2022).

Suriya Prakash was first appointed on 09 May 2022 as Managing Director at Immuno Cure Rite Medical Equipments Private Limited.

The current boards of Suriya Prakash's companies include Kaviya (Immuno Cure Rite Medical Equipments Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available